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Crystallisation is a very important technique, especially in the pharmaceutical industry, as it is 64 
used in the formation, purification and recovery of the crystalline active pharmaceutical 65 
ingredients (API) [1-3]. Despite this, crystallisation fundamentals are still insufficiently 66 
understood. Efforts have previously been made to understand the kinetics of salicylamide 67 
nucleation [4]. The present research focuses on advancing our knowledge of the crystal growth 68 
process of the same compound, in particular the kinetics. Crystal growth is known to be 69 
significantly influenced by the crystallisation environment [5]. This study centres on studying 70 
crystal growth of salicylamide under multi-particle crystallisation conditions [6-10]. This is 71 
further investigated by using different environmental conditions, including solvent, 72 
supersaturation and temperature, in order to determine which has the biggest impact on growth 73 
[11-13]. These multi-particle crystal growth experiments provide overall growth rates for the 74 
entire crystal population in the crystallisation reactor, which represents industrial process 75 
conditions [14, 15]. The studies were performed using mixing i.e. controlled hydrodynamic 76 
environment. Investigating this gives a good insight into the overall crystal growth kinetics and 77 
mechanism of the model API.  78 
Salicylamide, C7H7NO2, molecular weight 137.14 g mol
-1
, was used as the model API. It is 79 
classified as a non-prescription drug with analgesic and antipyretic properties, and used as an 80 
over-the-counter pain remedy. Salicylamide is supplied as white, mainly blocky or plate-like 81 
crystals, with a melting point of 138.7 °C [16]. Salicylamide has two polymorphs reported in 82 
the literature; FI and FII. FI, monoclinic I2/a, is the stable polymorph at ambient conditions 83 
whereas FII, orthorhombic P212121, is only obtained under high pressure [17]. For this reason 84 
only FI will be used in this study. The solubility of salicylamide FI in acetone, acetonitrile, 85 
ethyl acetate and methanol has already been determined between 10 °C and 50 °C by 86 
Nordstrӧm and Rasmuson [16].  87 
  88 
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In a supersaturated solution, crystal growth proceeds by bulk diffusion of growth units through 90 
the solution boundary layer surrounding the crystal, followed by step-wise desolvation, surface 91 
diffusion over the crystal face and integration into the crystal lattice, preferably at steps and 92 
kinks [2, 3]. These stages are essentially acting in series whereby the slowest one will be rate 93 
determining. By increasing the turbulence in the bulk solution around the crystal the boundary 94 
layer mass transfer becomes faster and the overall rate of growth becomes more surface 95 
integration controlled. The rate of growth of a crystal has a complex dependence on 96 
temperature, supersaturation, size, habit, system turbulence, crystallisation process etc. [3], and 97 
can be described by more or less empirical equations. Very commonly a simple power law 98 
equation is used eq 1, which only contains an explicit dependence on the supersaturation. This 99 
equation can be modified to also include explicit temperature dependence as in eq 2. 100 
Simple Overall Growth Rate Equation:  101 
g
g(s) , where  = -1 or TG k s s S      (1) 102 
Modified Overall Growth Rate Equation:  103 
ga
g0(s) exp , where  = -1 or T
E






  (2) 104 
Specifically for the surface integration step, two face growth rate models are commonly used. 105 
Burton, Cabrera and Frank (BCF) described the screw dislocation mechanism, eq 3. The BCF 106 
model involves diffusion of solute molecules over the crystal face which then incorporate onto 107 
dislocations that are present on the surface. This leads to the formation of a stepped surface, 108 
which subsequently forms a spiral that acts as a permanent source of growth steps [9]. As there 109 
is a permanent supply, growth can continue at low supersaturation as nucleation is not required. 110 
In other words, parameter A (eq 4) describes the crystal surface, and parameter B (eq 5) takes 111 
the physical properties of the crystal growth system into account. A has strong temperature 112 
dependence, whereas B is independent of temperature. The birth and spread (B&S) growth 113 
mechanism, eq 6, relies on crystal surface nucleation (birth), followed by the growth (spread) 114 
of the monolayers. This requires a higher supersaturation than the BCF model, as 2D 115 
nucleation is essential when there are no surface steps present. This surface nucleation can 116 
develop at any location on a crystal surface, e.g. edges, corners and on the faces. Further 117 
surface nuclei can develop on the monolayer nuclei as they spread across the crystal face [3]. 118 
The B&S model contains two parameters, C (eq 7) and D (eq 8), which describe very similar 119 
properties of the crystal growth system as their respective counterparts (A and B) in the BCF 120 
model. Also, analogous to the BCF model, C and D are temperature dependent and 121 
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The Spiral Growth model (BCF): 127 














tanhln1BCF                                (3) 128 
                          (4, 5) 129 
 130 
 131 
The Birth and Spread model (B&S): 132 
















stepSB       (6)                133 
                 (7, 8) 134 
 135 
 136 
The face growth models contain parameters A and C, respectively, which both rely heavily on a 137 









    (9) 139 
This is simply an Arrhenius equation with emphasis on the activation energy of the surface 140 
diffusion of adsorbed molecules, Ea, surf.  141 
Both models also have a term for the interfacial energy between solid-liquid, γsl, playing a key 142 
role in the B and D parameters. The solid-liquid interfacial energy in the B+S model in eq 8 143 
describes the radius of the 2D critical nuclei that form on the surface and are the source of new 144 
growth steps. B and D both incorporate physical properties of the crystal growth system, such 145 
as molecular volume, Vm, of salicylamide which is equal to 0.171 nm
3
 as obtained from the 146 
crystal density, assuming the height of the growth step, h, is equal to the cubic root of Vm i.e. 147 
0.56 nm. The parameter k denotes the Boltzmann constant and xs is the diffusion mean free 148 
path over the surface.  149 
Concentration decay can be related to the size change of the seed crystals through a mass 150 
balance, where the crystal length can be obtained by integration of the growth rate for 151 
G(Δc(t),T) = f(α, β, χ, ... ) where α, β, χ, ... are parameters of the growth rate models to be 152 
determined by optimization. In the simple growth rate eq 1, kg0, g are determined; in the 153 
modified growth rate eq 2, kg0, g, Ea are determined; in the BCF model, eq 3, A and B are 154 
determined, and in the B&S model, eq 6, C and D are determined. Optimization is performed 155 
with MATLAB, using the lsqcurvefit function and confidence intervals calculated using the 156 
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The true thermodynamic driving force for crystallization, Δμ (J mol
-1
), is the difference in 158 
chemical potential between the solute in the supersaturated solution and in the corresponding 159 









        (10) 161 
This expression is commonly simplified by neglecting the activity coefficient ratio entirely, 162 
and is often represented simply by a concentration ratio, S, or by using eq 11 as being an 163 






            (11) 165 
In a recently proposed method, an approximate representation of the activity coefficient ratio is 166 
obtained by neglecting only the temperature dependence, but not the concentration dependence, 167 











       (12) 169 
where γ for the supersaturated solution has been replaced by the corresponding value for the 170 
solution at its saturation temperature. For solutions that are not too dilute, i.e. in the Henry’s 171 
law region, this method is expected to be more accurate than neglecting the activity coefficient 172 
contribution to the driving force [18]. However, the solubility of salicylamide in at least two of 173 
the evaluated solvents (methanol and acetonitrile) is low enough that it cannot be stated with 174 
certainty that the temperature dependence of the activity coefficient is negligible. In this study, 175 
both representations of the driving force given by eqs 11 and 12 are used and compared. 176 
Further details are given in the Supporting Information. 177 
Experimental 178 
Materials  179 
Salicylamide (purity ≥ 99.0 %) was purchased from Sigma Aldrich (catalogue number 84230), 180 
and used as received without further purification. The solvents: Acetone (AC) 99.8 %, 181 
Acetonitrile (MeCN) ≥ 99.9 %, Ethyl Acetate (EA) 99.7 % and Methanol (MeOH) 99.9 % 182 
were also purchased from Sigma Aldrich and used as received.  183 
 184 
Metastable Zone Width Determination  185 
Metastable Zone Widths (MSZW) were determined in order to establish suitable levels of 186 
initial supersaturation in the crystal growth experiments. The MSZW studies involve cooling a 187 
saturated solution in an agitated jacketed 500 mL glass reactor with an inner diameter of 75 188 
mm, using a 60 mm 4-pitched-blade PTFE coated impeller with inclined blades rotating at 400 189 
rpm, under a specific decreasing temperature rate, controlled by circulator (Lauda, RE305 190 
series). A Focused Beam Reflectance (FBRM) probe (Mettler-Toledo) was used to detect total 191 
counts of crystals in situ, i.e. this ensured that no unwanted nucleation was observed. The 192 
MSZW is quantified by taking note of the time when the experiment started, the time at which 193 
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nucleation occurred and the temperature in vessel at this time. MSZW determination 194 
experiments were performed at four saturation temperatures (15 °C, 20 °C, 25 °C, and 30 °C) 195 




, and 1.5°C min
-1
) for each of the four 196 
solvents (AC, MeCN, EA and MeOH). Acetone provides for the widest metastable zone for 197 
salicylamide, followed by ethyl acetate and methanol, and then acetonitrile. Details are given in 198 
the Supporting Information – Figure S1. 199 
 200 
Crystal Growth Rate Determination 201 
Seeded isothermal desupersaturation experiments were performed according to a multi-particle 202 
crystal growth procedure. A known amount of sized seeds (300-355 μm) were suspended in a 203 
slightly supersaturated solution (200 mL) in the same reactor as was used for the MSZW 204 
studies with inclined blades rotating at 500 rpm. The initial supersaturation was low to avoid 205 
nucleation (S < 1.06), solution was heated to temperature 6 °C above saturation temperature. 206 
The reactor was kept at a constant crystal growth temperature by using a circulator (Lauda, 207 
RE305 series), and the decay in supersaturation was recorded over time. An attenuated total 208 
reflectance Fourier transform infrared probe, ATR-FTIR (Mettler-Toledo ReactIR
TM
 iC 10) 209 
was utilized to measure the solution concentration in situ. The system operates in the mid-IR 210 
region, from 1900 cm
-1
 to 650 cm
-2
, with 152 scans every minute. The decay in the solution 211 
concentration over time is proportional to the mass deposition on existing crystals, i.e. crystal 212 
growth. This concentration decay undergoes first principles data treatment using the built-in 213 
feature within the IR software to extract the concentration information from the IR spectra. A 214 
FBRM probe was also utilized to detect unwanted nucleation. Experiments were performed at 215 
four crystal growth temperatures (10 °C, 15 °C, 20 °C, and 25 °C) for each of the four solvents 216 
(AC, MeCN, EA and MeOH). More details are provided in our previous work [10].  217 
  218 
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Figure 1 shows the recorded supersaturation decay data as a function of time and the 220 
corresponding curve obtained in the fitting of the simple overall growth rate equation, eq 1, to 221 
the data. The corresponding crystal growth rate as a function of supersaturation in the four 222 
solvents at four different temperatures are given in the diagrams to the right. The growth rates 223 
increases with increasing temperature in all four solvents as expected, but the increase is not 224 
entirely even. The growth rates increase with supersaturation, and range up to 0.4 ms
-1
 which 225 
is in agreement with growth rates previously reported in the literature [10]. The maximum 226 
growth rate depends on the solvent and the temperature, but this is mostly governed by 227 
experimental conditions and limitations (e.g. assuming that nucleation does not occur). 228 
Parameters of eq 1 are given in the Supporting Information – Table S1. The growth order 229 
parameter g is in all cases above unity, indicating that crystal growth is at least partly 230 
controlled by the surface integration as was also found for salicylic acid [10]. No clear trend 231 
can be found in how the parameters, g and kg change with temperature or with solvent, since a 232 
significant parameter correlation is likely to exist between the g and the kg values for each case 233 
[19]. 234 
The modified overall growth rate equation, eq 2, has been fitted to the experimental 235 
desupersaturation data using the two driving force representations given by eq. 11 and eq 12, S-236 
1 and ΔμT. As shown in Figures 3 (ΔμT) and S2 (S-1), regardless of the driving force 237 
approximation used, the temperature dependence becomes more even compared to using eq 1. 238 
This is expected since the temperature dependence is built into the growth rate equation and is 239 
determined by fitting to all data at all temperatures for each solvent. As is shown in Figure 3, 240 
with respect to the influence of the solvent there is a difference between the two driving force 241 
representations, originating from the fact that the correction for the activity coefficient ratio is 242 
solvent and temperature dependent. Notably, using ΔμT leads to a less temperature dependent 243 
influence of the solvent, i.e. at both temperatures shown in Figure 3, the order of growth rates 244 
at equal driving force essentially is: MeCN > MeOH > AC > EA. When representing the 245 
driving force in terms of relative supersaturation (S-1), the order between the solvents changes 246 
with temperature: at 25 °C, the order is the same as when using ΔμT, whereas at 10 °C the order 247 
is MeOH > AC > MeCN > EA. The growth model, eq 2, takes temperature effects on kinetics 248 
into account. ΔμT also takes temperature effects on the driving force into account, which is not 249 
the case using S-1 as a driving force representation. The results stress the importance of the 250 
choice of representation of the driving force when growth rates in different solvents and at 251 
different temperatures are compared, as previously found for salicylic acid [10]. 252 
Figure 4 shows the saturated solution properties of salicylamide in acetone, acetonitrile, ethyl 253 
acetate and methanol. The mass ratio solubility shown in Figure 4a is calculated from the mole 254 
fraction solubility. In mass ratio terms, the solubility of salicylamide is relatively high in 255 
acetone and lower in methanol, ethyl acetate and acetonitrile. Solubility regression curves are 256 
also plotted in the figures over a temperature range from 10 °C to 25 °C, which is used in this 257 
study. Activity coefficients of salicylamide at saturation in these four solvents are plotted in 258 
Figure 4b. The activity coefficient of salicylamide at saturation in acetonitrile (2.13 – 1.95) is 259 
greater than in methanol (1.62 – 1.61), ethyl acetone (0.87 – 0.79) and acetone (0.51 – 0.44). A 260 
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value of the activity coefficient higher than unity implies that solute-solute interactions are 261 
more favorable than interactions between solute-solvent (acetonitrile or methanol); in contrast, 262 
relatively strong interactions between solute-solvent result in values of the activity coefficient 263 
below 1 (ethyl acetate and acetone). The comparatively strong solute-solute interactions 264 
predicted in acetonitrile and methanol are substantiated by experimental findings showing 265 
these solvents do in fact lead to faster growth rates compared with the other systems. With 266 
increasing temperature, the solution behavior approaches ideality, and values of the activity 267 
coefficient in all solvents tend towards unity. The molar ratio of solvent to solute in saturated 268 
solution and mole fraction solubility are compared at different temperatures in Figure 4c,d. 269 
Unsurprisingly, the molar ratio of acetonitrile to salicylamide is much higher compared with 270 
the values in other solvents due to the lower solubility of salicylamide in acetonitrile. 271 
In Table 1 the parameters obtained by fitting eq 2 to the experimental data are given. 272 
Regardless of solvent and driving force representation used, the g value is above unity as was 273 
also found using eq 2, indicating again that the crystal growth is at least partly controlled by the 274 
surface integration. The g value changes with the solvent, overall corresponding to the 275 
influence on the growth rate. The lowest g value is found in methanol where the growth rate is 276 
the highest, and the highest g value is found in ethyl acetate where the growth rate is the 277 
lowest. This relation is logical since a lower growth rate can be due to a slower surface 278 
integration for which we would expect a higher g value, and vice versa. The order between the 279 
solvents with respect to the value of g does not depend on the driving force representation, and 280 
in fact the numerical value is only moderately influenced by the driving force choice, with a 281 
tendency of being lower when using S-1. The rate constant value kg0 when using S-1 has the 282 
units of m/s and in all cases receives a numerical value of the expected order of magnitude. The 283 
corresponding rate constant when using ΔμT has units of J/mol and the variation depending on 284 
the solvent is several orders of magnitude. Again, it can be suspected that much of the variation 285 
stems from numerical correlation between parameters. 286 
As shown in Figure 2, the growth rate is strongly dependent on the temperature. In methanol, at 287 
a driving force of ΔμT = 20 Jmol
-1
, the growth rate increases by a factor 7 when the temperature 288 
is increased from 10 °C to 25 °C. The corresponding factor in acetone is 4. This strong 289 
dependence is of course reflected in the activation energies, Ea, with values given in Table 1. 290 
The activation energy order with respect to the solvent when using ΔμT is: MeCN > MeOH > 291 
EA ≥ AC. When using S-1 the activation energy obtained in EA is lower than in AC. It is worth 292 
noting that while g does not depend strongly on the driving force representation, the activation 293 
energy, Ea, does, and the higher value obtained in methanol when using ΔμT, is more in line 294 
with expectations. These activation energies are clearly higher than the values expected for 295 
simple molecular diffusion (5 – 20 kJmol
-1
), and nearer those reported for surface integration 296 
(40 – 60 kJmol
-1
) [3]. The surface integration step contains different physicochemical 297 
processes like desolvation, surface diffusion and lattice integration. All data together suggest 298 
that the crystal growth depending on the solvent and temperature is at least partly governed by 299 
the surface integration, and since there is a clear dependence of the solvent perhaps desolvation 300 
plays an important role. 301 
 302 
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Figure 1. Graphs to the left show supersaturation decay curves (dots are experimental values 328 
and lines are fits of eq 1), and graphs to the right show the corresponding growth rate curves, at 329 
four temperatures in four solvents. 330 
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Figure 2. Growth rate curves at four temperatures in four solvents obtained by fitting 342 












Figure 3. Effect of temperature and driving force representation on growth rate in four solvents, 355 
at two temperatures, obtained by fitting experimental results to the modified growth rate eq 2 356 
with the driving force s represented by S-1 and ΔμT, respectively. 357 
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Figure 4. Solubility of salicylamide: scatter plot obtained from experimental data and solid line 360 
obtained from regression curves (a); activity coefficients in saturated solution (b); molar ratio 361 
of solvent to solute (c) and mole fraction of solute (d). 362 
 363 
Table 1. Parameters of eq 2, given with 95 % confidence limit for desupersaturation 364 
experiments in four solvents. 365 
   gg S
RT
E








Solvents kg0 x 10
5
, m/s g Ea, kJ/mol kg0, m/s/(J/mol)
 
 g Ea, kJ/mol 
MeOH 1.12 ± 0.94 1.12 ± 0.03 60.06 ± 2.1 
(1.50 ± 1.73) x10
7
 1.15 ± 
0.02 
88.4 ± 2.9 
AC 12.8 ± 23.3 1.37 ± 0.04 58.70 ± 4.0 
15.2 ± 4.77 1.41 ± 
0.01 
58.5 ± 8.3 
MeCN 4.97 ± 5.65 1.28 ± 0.03 96.40 ± 2.6 
(3.15 ± 1.28) x10
7
 1.32 ± 
0.02 
91.2 ± 1.1 
EA 1.83 ± 2.68 1.40 ± 0.04 55.90 ± 3.3 
(2.72 ± 2.56) x10
4
 1.60 ± 
0.04 
80.7 ± 2.5 
 366 
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It should be stressed that the difference between the different driving force representations can 367 
be significant, and moreover, the difference is highly solvent-dependent. As expounded in the 368 
Supporting Information, the largest difference observed between Δμ calculated by including 369 
and neglecting the activity coefficient contribution, respectively, is 37 % in acetone, while in 370 
methanol the difference is close to zero. This is due to the fact that activity coefficients, and 371 
their influence on Δμ, depend on the solvent. The difference between the two representations 372 
not only depends on solvent, however, but also on temperature; increasing temperature results 373 
in a decrease in the difference between the representations in MeOH (from 5 % to -3 %) and 374 
EA (from 28 % to 24 %), while it remains virtually constant at all temperatures in AC (37 %) 375 
and MeCN (22 %). ΔμT accounts for the concentration dependence of the activity coefficient, 376 
which in many cases is expected to dominate the total influence of non-ideality on the driving 377 
force. [18] However, it should be noted that some solutions evaluated in this work are fairly 378 
dilute, and thus that the temperature dependence of the activity coefficient is expected to be 379 
more important than assumed in the derivation of eq 12. For these cases, we cannot state with 380 
certainty that ΔμT is a better approximation than S-1. 381 
In applying the BCF and the B&S equations, it should be noted that the crystal growth rate data 382 
obtained from seeded desupersaturation experiments represents an average over a number of 383 
crystals growing simultaneously, as well as an average over the growth of different faces. 384 
Accordingly, in the application of face growth models to such data the physical parameters 385 
determined have to be understood as averages over the different faces [10]. Both growth 386 
models provide good fits to the experimental data, as shown in Figure S3 of the Supporting 387 
Information. The BCF model gives a slightly better fit at 10 °C and 25 °C according to the 388 
residual curves. 389 
Table 2 and Table 3 list the fitted parameters of the BCF and B&S models, and the surface 390 
diffusion dependent parameters A and C for each solvent are plotted versus the inverse 391 
temperature in Figure 5. In all cases the graphs show a reasonably linear increase in the 392 
parameter value with decrease in inverse temperature from which the surface diffusion 393 
activation energy, Ea,surf, is determined according to eq 9. The surface diffusion activation 394 
energies are given in Tables 2 and 3 and for both models follow the same order with respect to 395 
the solvent as obtained for the activation energy above for eq 2 using ΔμT : MeCN > MeOH > 396 










Figure 5. Influence of temperature on BCF and B&S parameters in different solvents. 407 
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, K m/s 
B, K Ea, surf, kJ/mol 
25
o
C 20oC 15oC 10oC 
MeOH 15.5 ± 0.1 10.3 ± 0.30 7.10 ± 0.24 4.04 ± 0.01 0.49 ± 0.10 61.78 
AC 12.2 ± 1.30 7.13 ± 0.73 4.94 ± 0.28 4.28 ± 0.13 0.77 ± 0.20 49.05 
MeCN 16.8 ± 1.90 8.46 ± 0.39 5.70 ± 0.18 2.57 ± 0.01 0.79 ± 0.13 84.56 
EA 7.74 ± 0.84 5.19 ± 0.33 2.93 ± 0.14 2.53 ± 0.01 3.15 ± 0.47 54.93 
 409 


















MeOH 8.15 ± 0.57 5.75 ± 0.16 3.83 ± 0.18 2.18 ± 0.07 87 ± 14 61.39 
AC 6.59 ± 0.80 3.87 ± 0.48 2.70 ± 0.20 2.45 ± 0.10 151 ± 30 46.53 
MeCN 8.41 ± 1.11 4.46 ± 0.24 3.09 ± 0.12 1.43 ± 0.04 125 ± 17 79.88 
EA 3.93 ± 0.43 3.02 ± 0.21 1.76 ± 0.09 1.54 ± 0.07 344 ± 52 46.97 
 412 
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According to the results, the crystal growth rate of salicylamide in the four different solvents at 415 
equal driving force (ΔμT) decreases in the order: MeCN > MeOH > AC > EA. Regardless of 416 
temperature, the growth rate in EA is clearly lower than in the other solvents and the growth 417 
rate in MeCN and MeOH is quite similar. When the driving force is described by S-1 the order 418 
is more dependent on temperature, but at 15 °C the order is MeOH > AC > MeCN > EA. In 419 
Figure 6, the latter data are compared with data from a study over primary nucleation of 420 
salicylamide in the same solvents [20], from which also approximate crystal growth rates are 421 
estimated. These estimates assume that the crystals become visible when they reach a size of 1 422 
m, which of course is only an arbitrary value based on the findings of R. Devi, M. Svard et al 423 
[21]. However, within this assumption, the crystal growth rates from the nucleation 424 
experiments are in the order of 20 times higher, as would be expected from the much higher 425 
supersaturation under which the crystals are grown in the nucleation experiments. However, 426 
the order of growth rates with respect to the solvent exactly matches the order found in the 427 
present study. Methanol provides the fastest growth for salicylamide crystals, both at the 428 
nucleus stage at high supersaturation and for the much larger seed crystals at lower 429 
supersaturation, whereas ethyl acetate leads to the slowest growth rates. This shows that the 430 
growth of salicylamide crystals of varying size (< 1 μm and 355 μm up to 1000 μm) and under 431 
different driving forces were influenced in the same way by the different solvents even though 432 
the growth mechanism may actually be different.  433 




























 Growth rate from present study
 434 
Figure 6. Growth rates obtained from multi-particle crystal growth studies at 15 °C with S-1 = 435 
0.01 (this work), compared with the growth rates obtained from nucleation studies at 15 °C 436 
with S-1 = 1 [20].  437 
The B parameter in the spiral growth model is directly proportional to the interfacial energy (eq 438 
5), and the D parameter in the birth and spread model is proportional to the interfacial energy 439 
raised to the power 2 (eq 8). Accordingly, based on the parameter values given in Table 2, the 440 
interfacial energy determined using the BCF model follows the order EA > MeCN ≥ AC > 441 
MeOH, while the order obtained using the B&S model is slightly different: EA > AC > MeCN > 442 
MeOH. According to eqs 5 and 8, a low interfacial energy leads to a high crystal growth rate, 443 
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which is in agreement with the results from the growth rate experiments reported in this work. 444 
It is widely accepted that the solid-liquid interfacial energy appears as a governing parameter 445 
also in crystal nucleation. For this reason, values previously reported from nucleation 446 
experiments are compared with interfacial energies obtained from crystal growth data using the 447 
B&S model in Figure 7. The interfacial energies obtained from nucleation experiments follow 448 
an order exactly opposite to that of the B&S growth data: MeOH > MeCN > AC > EA. In the 449 
BCF theory the interfacial energy determines the radius of the growth spiral, while in the B&S 450 
theory the interfacial energy is based on the "birth" term of the B&S equation which can be 451 
considered as a 2D nucleation on a substrate surface, which explains why the interfacial energy 452 
obtained from crystal growth data is expected to be significantly smaller than that obtained 453 
from nucleation data (3D nucleation). However, at present we have no clear explanation why 454 
the influence of the solvent on the interfacial energy as determined from crystal growth and 455 
nucleation experiments, respectively, show completely opposite trends, and this disagrees with 456 
our previous findings for salicylic acid [20]. One possibility would be that the faces governing 457 
the crystal growth process do not have the same importance for the formation of nuclei. It is 458 
well understood that the supersaturation dependence of the growth rate of different faces can be 459 
different leading to that faces governing the growth at low supersaturation do not necessarily 460 
have to be the same as those that govern the growth rate at high supersaturation. 461 




























Figure 7. Interfacial energies obtained from the fitted parameter D of the B+S crystal growth 463 
model for growth data compared with values obtained using the classical nucleation theory 464 
from previously published nucleation data [20]. 465 
We have previously reported a similar crystal growth study on salicylic acid [10]. Salicylic 466 
acid (SA) has an identical molecular structure except for the amide group in the meta-position 467 
being replaced by a carboxylic acid group. Various properties of the two solutes are shown in 468 
table S4 in the Supporting Information. The molecular weight is essentially the same, while the 469 
melting temperature of SA is about 20 K higher, and the crystal density of SA is somewhat 470 
higher and accordingly the molecular volume is a bit lower. The hydrogen bonding capability 471 
differs somewhat, contributing to differences in the crystal structures. Both salicylic acid and 472 
salicylamide molecules form dimers, but in addition to this motif the SAM molecules are also 473 
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involved in other intramolecular hydrogen bond interactions. Ultimately, the differences in the 474 
hydrogen bonding are likely to play a significant role in the variances of growth rates obtained 475 
for the two solutes; however the details need to be investigated in further work. The packing 476 
arrangements in the two structures differ considerably as illustrated in Figure 8. Because of the 477 
structural differences, the two compounds crystallize in completely different habits, as is 478 
further discussed below. 479 
Salicylic Acid (SA) Salicylamide (SAM) 
 
 
Figure 8. Unit cell representations showing hydrogen bonds (blue lines) the two solutes, 480 
salicylic acid versus salicylamide were obtained using the software Materials Studio for 481 
structures with CSD refcodes: SALIAC16 and SALMID. 482 































































Figure 9. Crystal growth rate curves at (a) 10 °C and (b) 25 °C for salicylamide (present work; 484 
dashed lines) and salicylic acid [10] (solid lines) in four solvents at different driving forces 485 
obtained by fitting experimental results to the modified growth rate eq 2 with the driving force, 486 
s, represented by ΔμT.  487 
 488 
In Figure 9, crystal growth rates of salicylamide are compared with salicylic acid in the same 489 
solvents at two temperatures. In both cases the driving force has been estimated according to eq 490 
12 using the same approximation of the activity coefficient ratio [18]. At lower temperatures, 491 
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the growth rates of the two compounds follow a similar solvent order, whereas at higher 492 
temperatures they follow a different order. For salicylamide, the growth rate at all temperatures 493 
decreases in the order: MeCN > MeOH > AC > EA, while for salicylic acid the solvent order 494 
changes with temperature: at 10 °C the order is MeCN > MeOH ≥ EA ≥ AC, while at 25 °C 495 
the order is EA > MeOH > MeCN ≥ AC. In summary acetonitrile provides the fastest growth 496 
kinetics for both solutes at 10 °C. Ethyl acetate provides the slowest growth rates for 497 
salicylamide, whereas acetone provides the slowest growth rates for salicylic acid consistently 498 
at both temperatures. Accordingly the order with respect to the solvent does not match 499 
perfectly for the two solutes. However it should be acknowledged that there is some 500 
uncertainty in the curves as shown in fitting; this could have a considerable effect on the 501 
solvent order in the case of salicylic acid for which the curves are close together. Salicylic acid 502 
exhibits a clearly faster growth than salicylamide in all solvents at the lower temperature 503 
(10 °C), whereas salicylamide has the faster growth in all solvents except EA at the higher 504 
temperature (25 °C) as illustrated in Figure 9. As regards the temperature dependence of the 505 
crystal growth rate, for salicylic acid in acetonitrile at ΔμT = 10 Jmol
-1









 when the temperature goes from 10 °C to 25 °C, which equates 507 









, i.e. a 536 % increase. This shows that under the evaluated conditions the 509 
impact of increasing temperature has a significantly greater impact on the growth rate of 510 
salicylamide than salicylic acid. Comparing the activation energies obtained by fitting eq 2 511 
using ΔμT it is notable that Ea values are significantly higher (from a factor 1.5 up to 4) for 512 
SAM in all the solvents. The Ea value for salicylic acid is in the range 22 – 67 kJmol
-1
 while for 513 
salicylamide the range is 58 – 91 kJmol
-1
.  514 
There appears to be no clear relationship between SAM and SA as regards the parameters kg0 515 
and g with respect to the solvent. Significantly higher kg0 values were obtained for salicylamide 516 
than salicylic acid. The values of the growth order parameter g are for all solvent-solute 517 
combinations above unity with slightly higher values observed for salicylic acid in all solvents 518 
except ethyl acetate [10]. In comparing the activation energies for surface diffusion it may be 519 
noted that for SAM the value in MeOH is about 50 % higher compared to SA, while the values 520 
in AC are roughly the same, the value in MeCN is very much higher (by a factor 5 – 10), and 521 
the value in EA is slightly lower. 522 
In Figure 10 interfacial energies determined from the parameter D in the B&S model are 523 
compared for the two solutes in the same four solvents. There is a clear tendency for an 524 
opposite dependence on the solvent, where for salicylamide the interfacial energy decreases in 525 
the order EA > AC > MeCN > MeOH, whilst for salicylic acid the corresponding order is 526 
MeOH > AC > MeCN > EA. Salicylic acid has higher interfacial energy values than 527 
salicylamide in all solvents except ethyl acetate. The influence of the solvent on the interfacial 528 
energy is of course due to the corresponding influence on the parameter D. Besides having a 529 
different order with respect to the solvent, the D values are clearly higher for salicylic acid, 530 
except in ethyl acetate. The C values are of a similar order of magnitude, but more different in 531 
MeCN and EA. For comparison, the B-parameter of the BCF theory is also clearly higher for 532 
salicylic acid than for salicylamide except in EA. 533 
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Figure 10. Interfacial energies obtained from the fitted parameter D of the B+S crystal growth 535 
model for salicylamide (SAM) and salicylic acid (SA [10]) crystals. 536 
It may be argued that a comparison of linear growth rates is not trivial, especially not for two 537 
different compounds, since the morphologies are different and growth rates in one linear 538 
dimension are not really comparable. In the present case, for both compounds the seed crystal 539 
size has been determined by the same method: sieving, assumed to fractionate the crystals in 540 
terms of the second largest linear dimension. However, as shown in Figure 11 the shapes are 541 
quite different. In determining the crystal growth rate by the seeded desupersaturation method 542 
it is assumed that the crystal shape is constant and thus that the desupersaturation rate is 543 





N k L G
dt
       (12) 546 
In the evaluation of the linear growth rate G the shape factor cancels out, i.e. as long as the 547 
morphology remains constant the actual shape is unimportant. For the same compound 548 
growing in different habits in different solvents the linear growth rates are not necessarily 549 
comparable. However, in the present study, the seed material used is the same regardless of the 550 
solvent and the extent of growth is fairly limited, which would reasonably enable comparison. 551 
On the other hand, if structures of two different compounds having different crystal shapes are 552 
compared, the linear growth rates are not directly comparable without recognising the 553 
difference in the shape factor, i.e. equal linear growth rate does not mean equal mass 554 
consumption rate. By a recalculation, a comparison can be made in terms of mass deposition 555 







SA dt k SA L
 
  
     
  
    (13) 557 
 558 
 559 
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Figure 11. Micrographs of a) salicylic acid and b) salicylamide crystals used as model crystals 564 
for dimensions analysis in Table 4.  565 
Table 4. Parameter values used for mass deposition rate per unit surface area calculations for 566 
the two compounds obtained from representative crystals as shown in Figure 11.  567 
 Salicylic Acid Salicylamide 
Crystal size, L (m) 1.63 × 10
-4
 3.28 × 10
-4
 




 2.59 × 10
-11
 




 6.39 × 10
-7
 
Density, ρ (kgm-³) 1440 1330 
 568 
























































































































Figure 12. Mass deposition rate per unit surface area at (a) 10 °C and (b) 25 °C for two 570 
different compounds salicylamide (present work; dashed lines) and salicylic acid [10] (solid 571 
lines), in four solvents at different driving forces obtained from experimental growth rates by 572 
eq 13, with the driving force, s, represented by ΔμT. 573 
 574 
a) b) 
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In Figure 12, mass deposition rates per unit area curves are shown for the two solutes in 575 
different solvents at two temperatures. Compared to the linear growth rate curves (Figure 9), 576 
there are no major qualitative changes. From Figure 12 (a) it is clear that SA has a significantly 577 
higher mass deposition rate per unit surface area in all the solvents compared to SAM at 10 °C. 578 
However, at 25 °C (Figure 12 (b)), the mass deposition rate of SAM is clearly higher in two out 579 




Out of four solvents, the crystal growth rate of salicylamide was found to be slowest in ethyl 584 
acetate under all conditions evaluated. For the remaining solvents, the order with respect to the 585 
growth rate of salicylamide depends on temperature, supersaturation and driving force 586 
representation. The growth kinetics are strongly affected by the temperature as reflected in the 587 
activation energy. The growth order parameter reveals that the crystal growth is at least partly 588 
controlled by surface integration, with the highest value being found in ethyl acetate where the 589 
growth rate is the lowest. Higher than expected activation energies and significant influence of 590 
the solvent indicate that desolvation is a governing process. The influence of the solvent on the 591 
growth rate of salicylamide is in good agreement with the corresponding growth rates obtained 592 
in primary nucleation experiments. The BCF model and the B+S model are both well fitted to 593 
the growth data, and the interfacial energies are estimated. As opposed to similar work on 594 
salicylic acid, interfacial energies from primary nucleation data have an opposite dependence 595 
on the solvent to that found for the present growth rate data. Compared with a similar study 596 
over the crystal growth rate of salicylic acid the influence of the solvent is essentially the same, 597 
with acetonitrile providing the fastest growth rate for both compounds. Salicylamide crystal 598 
growth has a stronger temperature dependence than salicylic acid crystal growth.  599 
  600 
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Symbols & Nomenclature 619 
a activity, dimensionless 620 
A BCF model parameter, K ms
-1 
621 
B BCF model parameter, K
2 
622 
Bstep  two-dimensional nucleation rate 623 
C  B+S model parameter, ms
-1
 624 
CV Crystal volume, m
3 
625 
D  B+S model parameter, K
2 
626 
dm/dt  Rate of increase of the linear dimension  627 
Ea  apparent activation energy, kJmol
-1 
628 
g growth rate order, dimensionless 629 
G  rate of change of characteristic dimension of crystal, ms
-1
 630 
h height of the growth step, nm 631 
ka surface area shape factor, dimensionless 632 
kg  parameter in modified growth rate equation (pre-exponential factor/ frequency factor), 633 
unit depends on s term of the driving force 634 
kv volumetric shape factor, dimensionless 635 
L characteristic dimension of crystal, m 636 
M Molecular weight, gmol
-1
 637 





Nt Total number of seed crystals, dimensionless 639 





s driving force, unit changes with representation 641 
S  supersaturation ratio, dimensionless 642 
SA  Surface area, m
2 
643 
S-1 relative supersaturation, dimensionless 644 
t  time, s 645 
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T  temperature, K 646 
νstep  step advancement rate in the B+S model 647 
x  mole fraction concentration, dimensionless 648 
Greek Letters 649 
γ  activity coefficient, dimensionless 650 
µ  chemical potential, Jmol
-1 
651 
∆µ  chemical potential difference, Jmol
-1 
652 
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Synopsis  723 
The crystal growth rate of salicylamide has been determined by seeded isothermal 724 
desupersaturation experiments in different organic solvents and at different temperatures. In 725 
situ ATR-FTIR spectroscopy was employed for the determination of solution concentration. 726 
The crystal growth rates were compared in organic solvents at the same driving force 727 
considering activity coefficient, and growth mechanisms were discussed. 728 
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